Athira Pharma Inc
Change company Symbol lookup
Select an option...
ATHA Athira Pharma Inc
AMRC Ameresco Inc
ET Energy Transfer LP
AHCO Adapthealth Corp
LPSN LivePerson Inc
BGSF BGSF Inc
NEE Nextera Energy Inc
PSB-Y PS Business Parks Inc
ADBE Adobe Inc
APWL Advanced Powerline Technologies Inc
Go

Health Care : Pharmaceuticals |
Company profile

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and stop neurodegeneration. The Company’s pipeline is built from its drug discovery platform, ATH platform and consists of a series of small molecules that are designed to target either the central nervous system (CNS), by crossing the blood brain barrier (BBB), or the peripheral nervous system. Its lead candidate, ATH-1017, is a subcutaneous administered, BBB-penetrating, small molecule hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) activator for the treatment of neurodegenerative disorders, with an initial focus on Alzheimer’s disease (AD). The Company also has preclinical candidates for non-AD indications, including ATH-1018, which is being developed to address peripheral indications, and ATH-1019 / ATH-1020 compounds, which are being advanced to address neuropsychiatric indications.

Closing Price
$13.07
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
421,045
0

Freeport-McMoRan Inc. Stock Falls Wednesday, Underperforms Market

4:54 pm ET September 29, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Freeport-McMoRan Inc. (FCX) slid 1.37% to $33.11 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.16% to 4,359.46 and the Dow Jones Industrial Average rising 0.26% to 34,390.72. This was the stock's second consecutive day of losses. Freeport-McMoRan Inc. closed $12.99 below its 52-week high ($46.10), which the company reached on May 10th.

The stock underperformed when compared to some of its competitors Wednesday, as BHP Group PLC ADR (BHP.LN) rose 0.04% to $49.76, BHP Group Ltd. ADR (BHP.AU) rose 0.11% to $52.62, and Rio Tinto PLC ADR (RIO.LN) fell 0.14% to $65.74. Trading volume (12.7 M) remained 5.6 million below its 50-day average volume of 18.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

September 29, 2021 16:54 ET (20:54 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.